These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26738505)

  • 21. Prostatic arterial embolization to treat benign prostatic hyperplasia.
    Pisco JM; Pinheiro LC; Bilhim T; Duarte M; Mendes JR; Oliveira AG
    J Vasc Interv Radiol; 2011 Jan; 22(1):11-9; quiz 20. PubMed ID: 21195898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial.
    Abt D; Müllhaupt G; Mordasini L; Güsewell S; Markart S; Zumstein V; Kessler TM; Schmid HP; Engeler DS; Hechelhammer L
    BJU Int; 2019 Jul; 124(1):134-144. PubMed ID: 30499637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI findings after prostatic artery embolization for treatment of benign hyperplasia.
    Frenk NE; Baroni RH; Carnevale FC; Gonçalves OM; Antunes AA; Srougi M; Cerri GG
    AJR Am J Roentgenol; 2014 Oct; 203(4):813-21. PubMed ID: 25247946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate Artery Embolization in Patients with Prostate Volumes of 80 mL or More: A Single-Institution Retrospective Experience of 93 Patients.
    Bhatia S; Sinha VK; Harward S; Gomez C; Kava BR; Parekh DJ
    J Vasc Interv Radiol; 2018 Oct; 29(10):1392-1398. PubMed ID: 30217744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia.
    Brown N; Walker D; McBean R; Pokorny M; Kua B; Gianduzzo T; Dunglison N; Esler R; Yaxley J
    BJU Int; 2018 Nov; 122 Suppl 5():27-34. PubMed ID: 30076682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early post-interventional sonographic evaluation of prostatic artery embolization. A promising role for contrast-enhanced ultrasonography (CEUS).
    Moschouris H; Stamatiou K; Kalokairinou Motogna M; Vrakas S; Kiltenis M; Kladis-Kalentzis K; Tsavdaroglou A; Papadogeorgopoulos N; Marmaridou K; Malagari K
    Med Ultrason; 2018 May; 20(2):134-140. PubMed ID: 29730677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.
    Teoh JY; Chiu PK; Yee CH; Wong HM; Chan CK; Chan ES; Hou SS; Ng CF
    Int Urol Nephrol; 2017 Feb; 49(2):197-203. PubMed ID: 27896579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.
    Carnevale FC; Iscaife A; Yoshinaga EM; Moreira AM; Antunes AA; Srougi M
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):44-52. PubMed ID: 26506952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computerized metric assessment of glandular tissue volume within the peripheral zone of the prostate using combined magnetic resonance imaging and histopathology: Possible pathophysiological implications on prostate cancer development.
    Wolpert JM; Presson C; Kimball N; Lin B; Brandi L; Helo N; de Riese WTW
    Investig Clin Urol; 2024 Jul; 65(4):334-341. PubMed ID: 38978213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the intra-prostatic arterial anatomy and implications for arterial embolization of benign prostatic hyperplasia.
    Anract J; Amouyal G; Peyromaure M; Zerbib M; Sapoval M; Barry Delongchamps N
    Prog Urol; 2019 Apr; 29(5):263-269. PubMed ID: 30948187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed Tomography for 4-Dimensional Angiography and Perfusion Imaging of the Prostate for Embolization Planning of Benign Prostatic Hyperplasia.
    Kobe A; Puippe G; Klotz E; Alkadhi H; Pfammatter T
    Invest Radiol; 2019 Oct; 54(10):661-668. PubMed ID: 31211710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale.
    Sun F; Crisóstomo V; Báez-Díaz C; Sánchez FM
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):161-9. PubMed ID: 26563245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-Enhanced Ultrasonography for the Early Evaluation of Prostate Artery Embolization.
    Barat M; Boeken T; Moussa N; Di Gaeta A; Déan C; Thioun N; Del Giudice C; Pellerin O; Sapoval M
    Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1498-1504. PubMed ID: 32435835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Bleomycin-Eluting versus Bland Microspheres in a Canine Model.
    Zhang JL; Yuan B; Wang MQ; Fu JX; Duan F; Wang T; Shen L; Wang Y; Liu JH; Shen YG; Wang XQ; Zhang HT; Li HW; Yan JY; Song ZG
    J Vasc Interv Radiol; 2020 May; 31(5):820-830. PubMed ID: 32305243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia.
    Ayyagari R; Powell T; Staib L; Chapiro J; Schoenberger S; Devito R; Pollak J
    J Vasc Interv Radiol; 2019 Sep; 30(9):1459-1470. PubMed ID: 31375451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semi-Automatic MRI Feature Assessment in Small- and Medium-Volume Benign Prostatic Hyperplasia after Prostatic Artery Embolization.
    Schmidt VF; Schirren M; Heimer MM; Kazmierczak PM; Cyran CC; Wildgruber M; Seidensticker M; Ricke J; Solyanik O
    Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.